Middle East & Africa Gastroparesis Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Middle East & Africa Gastroparesis Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Gastroparesis Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Middle East & Africa Gastroparesis Market Regional Analysis

6.2 Middle East & Africa Gastroparesis Market Revenue 2018-2027 (US$ Million)

6.3 Middle East & Africa Gastroparesis Market Forecast Analysis

7. Middle East & Africa Gastroparesis Market Analysis – by Type

7.1 Idiopathic

7.1.1 Overview
7.1.2 Idiopathic: Middle East & Africa Gastroparesis Market – Revenue and Forecast, 2018-2027 (US$ Million)

7.2 Diabetic

7.2.1 Overview
7.2.2 Diabetic: Middle East & Africa Gastroparesis Market – Revenue and Forecast, 2018-2027 (US$ Million)

7.3 Post-Surgical

7.3.1 Overview
7.3.2 Post-Surgical: Middle East & Africa Gastroparesis Market – Revenue and Forecast, 2018-2027 (US$ Million)

8. Middle East & Africa Gastroparesis Market Analysis – by Drug Class

8.1 Prokinetic Agents

8.1.1 Overview
8.1.2 Prokinetic Agents: Middle East & Africa Gastroparesis Market – Revenue and Forecast, 2018-2027 (US$ Million)

8.2 Botulinum Toxin Injections

8.2.1 Overview
8.2.2 Botulinum Toxin Injections: Middle East & Africa Gastroparesis Market – Revenue and Forecast, 2018-2027 (US$ Million)

8.3 Antiemetic Agents

8.3.1 Overview
8.3.2 Antiemetic Agents: Middle East & Africa Gastroparesis Market – Revenue and Forecast, 2018-2027 (US$ Million)

9. Middle East & Africa Gastroparesis Market Analysis – by Distribution Channel

9.1 Retail Pharmacies

9.1.1 Overview
9.1.2 Retail Pharmacies: Middle East & Africa Gastroparesis Market – Revenue and Forecast, 2018-2027 (US$ Million)

9.2 Hospital Pharmacies

9.2.1 Overview
9.2.2 Hospital Pharmacies: Middle East & Africa Gastroparesis Market – Revenue and Forecast, 2018-2027 (US$ Million)

10. Middle East & Africa Gastroparesis Market – Middle East and Africa Analysis

10.1 Overview

10.2 Middle East and Africa

10.2.1 Middle East & Africa Gastroparesis Market Breakdown, by Key Country, 2021 and 2027 (%)
10.2.1.1 Middle East & Africa Gastroparesis Market – Revenue and Forecast Analysis – by Country
10.2.1.1 South Africa: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 South Africa: Middle East & Africa Gastroparesis Market Breakdown, by Type
10.2.1.1.2 South Africa: Middle East & Africa Gastroparesis Market Breakdown, by Drug Class
10.2.1.1.3 South Africa: Middle East & Africa Gastroparesis Market Breakdown, by Distribution Channel

10.2.1.2 Saudi Arabia: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Saudi Arabia: Middle East & Africa Gastroparesis Market Breakdown, by Type
10.2.1.2.2 Saudi Arabia: Middle East & Africa Gastroparesis Market Breakdown, by Drug Class
10.2.1.2.3 Saudi Arabia: Middle East & Africa Gastroparesis Market Breakdown, by Distribution Channel

10.2.1.3 UAE: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 UAE: Middle East & Africa Gastroparesis Market Breakdown, by Type
10.2.1.3.2 UAE: Middle East & Africa Gastroparesis Market Breakdown, by Drug Class
10.2.1.3.3 UAE: Middle East & Africa Gastroparesis Market Breakdown, by Distribution Channel

10.2.1.4 Rest of Middle East and Africa: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Gastroparesis Market Breakdown, by Type
10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Gastroparesis Market Breakdown, by Drug Class
10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Gastroparesis Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Allergan Plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Ipca Laboratories Ltd.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Johnson and Johnson Services, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Pfizer Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 TEVA PHARMACEUTICAL INDUSTRIES LTD

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Middle East & Africa Gastroparesis Market

Analysis By Type (Idiopathic, Diabetic, Post-Surgical, and Others), Drug Class (Prokinetic Agents, Botulinum Toxin Injections, and Antiemetic Agents), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others)